tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

NuVasive price target raised to $58 from $56 at Barclays

Barclays analyst Matt Miksic raised the firm’s price target on NuVasive to $58 from $56 and keeps an Overweight rating on the shares. The company delivered solid Q2 sales results and upside to earnings, but sales fell just shy of consensus, the analyst tells investors in a research note. While investors may question whether the business is losing momentum, NuVasive’s operating performance was solid, says the firm.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Read More on NUVA:

Disclaimer & DisclosureReport an Issue

1